B
Bettina F. Cuneo
Researcher at University of Colorado Denver
Publications - 139
Citations - 5358
Bettina F. Cuneo is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Medicine & Fetal echocardiography. The author has an hindex of 35, co-authored 114 publications receiving 4275 citations. Previous affiliations of Bettina F. Cuneo include Children's Memorial Hospital & University of Colorado Boulder.
Papers
More filters
Journal ArticleDOI
Diagnosis and Treatment of Fetal Cardiac Disease A Scientific Statement From the American Heart Association
Mary T. Donofrio,Anita J. Moon-Grady,Lisa K. Hornberger,Joshua A. Copel,Mark Sklansky,Alfred Abuhamad,Bettina F. Cuneo,James C. Huhta,Richard A. Jonas,Anita Krishnan,Stephanie Lacey,Wesley Lee,Erik C. Michelfelder,Gwen R. Rempel,Norman H. Silverman,Thomas L. Spray,Janette F. Strasburger,Wayne Tworetzky,Jack Rychik +18 more
TL;DR: This statement highlights what is currently known and recommended on the basis of evidence and experience in the rapidly advancing and highly specialized field of fetal cardiac care.
Journal ArticleDOI
Frequency of 22q11 deletions in patients with conotruncal defects
Elizabeth Goldmuntz,Bernard J. Clark,Bernard J. Clark,Laura E. Mitchell,Laura E. Mitchell,Abbas F. Jawad,Abbas F. Jawad,Bettina F. Cuneo,Lori Reed,Donna M. McDonald-McGinn,Peggy Chien,Jennifer Feuer,Elaine H. Zackai,Elaine H. Zackai,Beverly S. Emanuel,Beverly S. Emanuel,Deborah A. Driscoll,Deborah A. Driscoll +17 more
TL;DR: A substantial proportion of patients with IAA, TA, TOF and PMVSD have a deletion of chromosome 22q11, which is more common in patients with aortic arch or vessel anomalies, and guidelines for deletion screening of Patients with conotruncal defects are defined.
Journal ArticleDOI
American society of echocardiography guidelines and standards for performance of the fetal echocardiogram
Jack Rychik,Nancy A. Ayres,Bettina F. Cuneo,Nina L. Gotteiner,Lisa K. Hornberger,Philip J. Spevak,Mary Van Der Veld +6 more
TL;DR: Improved operator skill amongst physicians performing general antepartum obstetrical ultrasound, in combination with increased sensitivity of present day ultrasound systems, has resulted in improved detection of fetal cardiovascular abnormalities and increased requirements for more detailed evaluation.
Journal ArticleDOI
Calmodulin mutations associated with recurrent cardiac arrest in infants
Lia Crotti,Christopher N. Johnson,Elisabeth Graf,Gaetano M. De Ferrari,Bettina F. Cuneo,Marc Ovadia,John Papagiannis,Michael D. Feldkamp,Subodh Rathi,Jennifer D. Kunic,Matteo Pedrazzini,Thomas Wieland,Peter Lichtner,Britt M. Beckmann,Travis Clark,Christian M. Shaffer,D. Woodrow Benson,Stefan Kääb,Thomas Meitinger,Tim M. Strom,Walter J. Chazin,Peter J. Schwartz,Alfred L. George +22 more
TL;DR: Human calmodulin mutations disrupt calcium ion binding to the protein and are associated with a life-threatening condition in early infancy, and a plausible molecular mechanism for potentially deadly disturbances in heart rhythm during infancy is identified.
Journal ArticleDOI
Amiodarone Therapy for Drug-Refractory Fetal Tachycardia
Janette F. Strasburger,Bettina F. Cuneo,Maaike M. Michon,Nina L. Gotteiner,Barbara J. Deal,Scott Mcgregor,Martijn A. Oudijk,Erik J. Meijboom,Leonard Feinkind,Michael J. Hussey,Barbara V. Parilla +10 more
TL;DR: Orally administered amiodarone is safe and effective treatment for drug-refractory fetal tachycardia, specifically reentrant supraventricular tachy Cardia, junctional ectopic, or ventricular tachCardia, even when accompanied by hydrops fetalis or Ventricular dysfunction.